Official Report · Committee
Co-location of General Medical Practices and Community Pharmacies (PE1492)
We come to item 5. PE1492 was referred to us last week by the Public Petitions Committee. Of course this relates to the evidence that we have just taken and to the SSI that we will consider formally later in the meeting.
As members will know, the committee paper suggests that we can either close the petition or allow it to remain open and return to the issue later in the parliamentary session. I invite comments from committee members on the paper before us.
link
We have just had a question-and-answer session that very much relates to the issues raised in the petition. I suspect that the committee will look—we obviously discuss our work plan in private in normal circumstances—at prescription for excellence again in the future. It is very much about the new relationship and dynamic between dispensing GPs, clinical pharmacists and community pharmacists and how we can better meet the needs of patients and constituents who are not getting the pharmaceutical care that we would like them to get.
Rather than close the petition or do a specific piece of work on it, I suggest that the next time that we scrutinise prescription for excellence we think about how we can incorporate some of the petition’s themes in our evidence session.
Is there an alternative view? As there is not, do we agree that we will allow the petition to remain open and that it will be a focus in our future discussions on prescription for excellence?
Members indicated agreement.
The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.